Impact of lisocabtagene maraleucel (liso-cel) treatment on health-related quality of life and health utility in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: TRANSCEND NHL 001 (NCT02631044)
BRITISH JOURNAL OF HAEMATOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要